Skip to main content
Equibles

CANADA LIFE ASSURANCE Co

Insurance

Position in EDIT — Editas Medicine, Inc.

CIK 1046192 WINNIPEG, A2
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$254,670
+$112,070 QoQ
Shares Held
78,602
+36.1% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CANADA LIFE ASSURANCE Co holds $335,351,557 across 80 Biotechnology names. EDIT ranks #54 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 182,365 $90,586,166
2 REGN
Regeneron Pharmaceuticals, Inc.
 86,761 $54,098,953
3 ALNY
Alnylam Pharmaceuticals, Inc.
 69,102 $20,801,775
4 INCY
Incyte Corp
 126,229 $14,309,319
5 ARGX
Argenx SE
 14,868 $13,794,084
6 MRNA
Moderna, Inc.
 152,228 $10,660,526
7 RPRX
Royalty Pharma plc
 185,316 $10,390,668
8 EXEL
Exelixis, Inc.
 155,922 $8,483,716

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $254,670 78,602
2026-03-31 $142,600 57,733
2025-12-31 $92,432 45,089
2025-09-30 $158,766 45,754
2025-06-30 $70,263 31,938
2025-03-31 $9,773 8,425
2024-12-31 $9,063 7,137
2024-09-30 $58,679 17,208
2024-06-30 $93,759 20,077
2024-03-31 $322,829 43,508
2023-12-31 $423,687 41,825
2023-09-30 $153,090 19,627
2023-06-30 $101,418 12,323
2023-03-31 $69,542 9,592
2022-12-31 $37,511 4,229
2022-09-30 $48,862 3,992
2022-06-30 $45,628 3,857
2022-03-31 $70,545 3,709
2021-12-31 $95,261 3,588
2021-09-30 $142,711 3,474
2021-06-30 $196,767 3,474
2021-03-31 $175,014 4,167
2020-12-31 $292,148 4,167
2020-09-30 $116,926 4,167
2020-06-30 $123,259 4,167
2020-03-31 $58,895 2,970